ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number 1985/0002935/06
Share code: APN ISIN: ZAE000066692
("Aspen Holdings" or "the Company")

NO CHANGE STATEMENT AND NOTICE OF ANNUAL GENERAL MEETING

Shareholders are advised that the Company's Integrated Report for the year ended 30 June 2014 has been finalised and that this report and the notice of the annual general meeting ("AGM") to be held
on 8 December 2014 will be posted to shareholders in due course. The Integrated Report, notice of AGM and the following documents are also available online at the Company's website www.aspenpharma.com:
- Corporate Governance Statement and reports of the Aspen Audit & Risk and Social & Ethics committees for the 2014 financial year ("Unabridged Corporate Governance Statement");
- the Aspen Group's Sustainability Report for the 2014 financial year ("Sustainability Report");
and
- the Annual Financial Statements the 2014 financial year ("AFS").
The AFS contain no modifications to the reviewed provisional results which were published on SENS on 10 September 2014. The AFS were audited by PricewaterhouseCoopers Inc. Their unqualified report is available for inspection at the Company's registered office.
Notice is hereby given that the 16th annual general meeting of the shareholders of the Company will be held at Building Number 1, Healthcare Park, Woodlands Drive, Woodmead, Johannesburg, Gauteng, on Monday, 8 December 2014 at 10:00.
Shareholders are advised that, due to the current ongoing labour disruption at the South African Post Office, they may experience postal delays and may not receive the notice of the AGM in time to submit proxy forms to the Company's share transfer secretaries (Computershare). Shareholders experiencing difficulty in this regard are requested to access the notice of AGM and other documents referred to above on the Company's website www.aspenpharma.com. A printable version of these documents in PDF format can also be emailed to shareholders upon request to the Company Secretary - mailto:rverster@aspenpharma.comrverster@aspenpharma.comor +27 31 580 8624.
Durban
29 October 2014
Sponsor
Investec Bank Limited

distributed by